Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results

CVRx, Inc. (CVRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 144 Form 144 - Report of proposed sale of securities:
08/07/2023 4 VERRASTRO PAUL (CHIEF MKTG & STRAT OFFICER) has filed a Form 4 on CVRx, Inc.
Txns: Sold 628 shares @ $18.5549, valued at $11.7k
08/03/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/02/2023 4 VERRASTRO PAUL (CHIEF MKTG & STRAT OFFICER) has filed a Form 4 on CVRx, Inc.
Txns: Sold 1,122 shares @ $17.4948, valued at $19.6k
Gifted 2,000 shares @ $0
Exercised 3,750 options to buy @ $5.141, valued at $19.3k
07/25/2023 8-K Quarterly results
06/08/2023 8-K Investor presentation
Docs: "2 Cautionary Note Regarding Forward-Looking Statement This presentation by CVRx, Inc. contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts are forward-looking statements, including statements regarding our future financial performance , our anticipated growth strategies, anticipated trends in our industry, our business prospects and our opportunities. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “outlook,” “guidance,” “intend,” “target,..."
06/07/2023 4 Behbahani Ali (Director) has filed a Form 4 on CVRx, Inc.
Txns: Granted 12,012 options to buy @ $12.33, valued at $148.1k
06/07/2023 4 Jain Mudit K. (Director) has filed a Form 4 on CVRx, Inc.
Txns: Granted 12,012 options to buy @ $12.33, valued at $148.1k
06/07/2023 4 SLATTERY JOSEPH P (Director) has filed a Form 4 on CVRx, Inc.
Txns: Granted 12,012 options to buy @ $12.33, valued at $148.1k
06/07/2023 4 Hykes Kevin (Director) has filed a Form 4 on CVRx, Inc.
Txns: Granted 12,012 options to buy @ $12.33, valued at $148.1k
06/07/2023 4 SHADAN MARTHA (Director) has filed a Form 4 on CVRx, Inc.
Txns: Granted 12,012 options to buy @ $12.33, valued at $148.1k
06/07/2023 4 Nielsen Kirk G. (Director) has filed a Form 4 on CVRx, Inc.
Txns: Granted 12,012 options to buy @ $12.33, valued at $148.1k
05/26/2023 SD Form SD - Specialized disclosure report:
05/18/2023 4 Palmer Craig E. (SVP, U.S. SALES) has filed a Form 4 on CVRx, Inc.
Txns: Exercised 295 options to buy @ $0.237, valued at $69.9
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/27/2023 8-K Quarterly results
04/21/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/21/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/21/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Totality of Evidence from BeAT-HF Study Shows CVRx’ s Barostim Provides Long-term Benefits for Patients with Heart Failure",
"Presentation of CVRx, Inc."
03/15/2023 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ...
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
02/10/2023 10-K Annual Report for the period ended December 31, 2022
02/06/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/03/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/26/2023 8-K Quarterly results
Docs: "CVRx, INC. Condensed Consolidated Balance Sheets December 31, December 31, 2022 2021 Assets Current assets: Cash and cash equivalents $ 106,194 $ 142,072 Accounts receivable, net of allowances of $679 and $0, respectively 5,504 2,560 Inventory 6,957 3,880 Prepaid expenses and other current assets 4,223 2,585 Total current assets 122,878 151,097 Property and equipment, net 1,698 1,425 Operating lease right-of-use asset 334 — Other non-current assets 27 26 Total assets $ 124,937 $ 152,548 Liabilities and Stockholders’ Equity Current liabilities: Accounts payable $ 1,719 $ 510 Accrued expenses 6,369 5,398 Total current liabilities 8,088 5,908 Long-term debt 6,747 — Operating lease liability, non-current portion 117 — Other long-term liabilities 805 681 Total liabilities 15,757 6,589 Commitme..."
01/20/2023 4 Galle Liz (VP OF GLOBAL CLINICAL RESEARCH) has filed a Form 4 on CVRx, Inc.
Txns: Granted 26,000 options to buy @ $15.22, valued at $395.7k
01/20/2023 4 Palmer Craig E. (SVP, U.S. SALES) has filed a Form 4 on CVRx, Inc.
Txns: Granted 40,000 options to buy @ $15.22, valued at $608.8k
01/20/2023 4 OASHEIM JARED (CFO) has filed a Form 4 on CVRx, Inc.
Txns: Granted 70,000 options to buy @ $15.22, valued at $1.1M
01/20/2023 4 VERRASTRO PAUL (CHIEF MKTG & STRAT OFFICER) has filed a Form 4 on CVRx, Inc.
Txns: Granted 45,000 options to buy @ $15.22, valued at $684.9k
01/20/2023 4 Yared Nadim (CEO) has filed a Form 4 on CVRx, Inc.
Txns: Granted 200,000 options to buy @ $15.22, valued at $3M
01/13/2023 4 Yared Nadim (CEO) has filed a Form 4 on CVRx, Inc.
Txns: Gifted 7,080 shares @ $0
01/09/2023 8-K Quarterly results
12/23/2022 4 Hykes Kevin (Director) has filed a Form 4 on CVRx, Inc.
Txns: Granted 5,246 options to buy @ $15.78, valued at $82.8k
Granted 21,776 options to buy @ $15.78, valued at $343.6k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy